Peri-implant Tissues in BLX® Implants
BLX
Behavior of Peri-implant Tissues in BLX® Implants Placed on Mature Scarred Bone
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a randomized triple-blind clinical trial to evaluate the behavior of peri-implant tissues (bone and soft tissues) in BLX implants loaded early or delayed and with different surgical milling protocols. To this end, 40 BLX implants with a diameter of 3.75x10 will be placed in areas of mature bone scarred after extraction. They will be divided into 2 study groups, and these in turn into two subgroups. Group A: complete milling, Group B: partial milling. Each group will be assigned with code 1: early load and code 2: deferred load. Clinical and radiological parameters will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2018
CompletedFirst Posted
Study publicly available on registry
October 25, 2018
CompletedStudy Start
First participant enrolled
November 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 19, 2020
CompletedJuly 7, 2020
July 1, 2020
2 months
October 5, 2018
July 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary stability of implants and peri-implant tissues
Randomly and following the inclusion and exclusion criteria, the implants will be placed with the normal preparation protocol (n = 20) and with the preparation protocol with under-fresh (n = 20). We will evaluate the immediate post-surgical stability of implants and peri-implant tissues through the Ostell system, based on the resonance frequency analysis (RFA). The implant stability quotient (ISQ) is the value on a scale that indicates the level of stability and osseointegration in dental implants. The scale ranges from 1 to 100, with higher values indicating greater stability. The acceptable stability range lies between 55-85 ISQ
12 months
Secondary Outcomes (9)
Basal Peri-implant tissue level: implant stability
1 day
Basal Radiological Bone Implant level
1 day
Basal Peri-implant tissue level: probing depth
1 day
Radiological bone implant stability
6 weeks
Peri-implant tissue stability: probing depth
6 weeks
- +4 more secondary outcomes
Other Outcomes (1)
Long-term evaluation of definitive prostheses
12 months
Study Arms (4)
Full preparation
EXPERIMENTALGroup A: the complete milling protocol indicated by the manufacturer for the 3.75x10 mm BLX implant will be performed.
Partial preparation
EXPERIMENTALGroup B: the partial / under milling protocol for the 3.75x10 mm implant, indicated by the manufacturer, will be carried out.
Deferred loading
EXPERIMENTALCode 2: for implants with this random code, the prosthetic prosthesis SRA of 2.5 mm and its corresponding healing plug of 5.1 mm will be placed. Impressions will be taken at 6 weeks to place the provisional prosthesis at 8 weeks. At 6 months the final impressions will be taken for the definitive load.
Immediate load
EXPERIMENTALThe code 1: to the implants with this random code, the prosthetic prosthesis SRA of 2.5 mm and its corresponding healing plug of 5.1 mm will be placed. The impression will be made in the same surgery and the placement of the provisional prosthesis before 7 days. At 6 months the final impressions will be taken for the definitive load.
Interventions
This is the first surgical phase, we prepare the implant bed by using different increasing size drills.
This is the second phase, based on prosthetic procedures, to design the crown over the dental implant
Eligibility Criteria
You may qualify if:
- Patients without systemic pathology
- Adult of age who agree to be part of the study and sign the informed consent.
- Patients smoking less than 5 cigarettes / day,
- Patients not being completely edentulous
- Unitary / multiple absences in the area posterior with or without free ends to distal, maxillary or mandibular that do not require regenerative techniques
- Area of mature bone healed at least 6 months post-extraction.
- The minimum torque for early loading will be 25 N. The placement of the implant will be mechanical up to 40 N maximum and manually finished with a surgical dynamometer.
- The placement of the abutment will be at a minimum of 25 N, in case the primary stability of the implant allows it, it will be placed at 35 N.
- The placement of the implant must always be 4 mm below the future gingival margi
You may not qualify if:
- Immunosuppressed patients
- Aesthetic edentulous areas of 13-23 and 33-43
- Smokers of more than 5 cigarettes
- Implants with a lower torque whose will be submerged with a screw and a protocol will be followed in 2 phases, being discarded from the study.
- Index of bleeding greater than 30%
- Patients with less than 2 mm of keratinized gingiva
- Implants with ISQ index \<55
- When a margin of 1 mm safety cannot be assumed to the inferior dental nerve
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Santiago de Compostelalead
- Manohay Dental SAUcollaborator
Study Sites (1)
Mario Pérez Sayáns
Santiago de Compostela, A Coruña, 15785, Spain
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mario Perez Sayans, PhD
University of Santiago de Compostela
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 5, 2018
First Posted
October 25, 2018
Study Start
November 2, 2018
Primary Completion
January 10, 2019
Study Completion
June 19, 2020
Last Updated
July 7, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- From the beginning to sex month after finishing the study
- Access Criteria
- Under request
We will anonymize and categorize the clinical and radiological data of the patients to share the information with the other researchers of the group (n=9)